Vision-related conditions affect around two out of three adults in the U.S., and the demand for ophthalmic care continues to rise. Despite the high number of affected individuals, patients still struggle with getting accurate diagnoses and treatments.
But why is this the case? Is it about the complexity of the eye treatments, or does the healthcare system not prioritize these patients?
Unfortunately, affordability and complicated insurance requirements are the primary reasons for this gap. Professionals sequentially encounter another common issue: prior authorization for specialized, costly, and complex ophthalmology services. The result? Delay in treatment.
It is necessary to break down why prior authorization takes longer in ophthalmology practices, the new guidelines for prior approvals, and some examples of complicated ophthalmology services that require pre-authorization.
But before we begin, let us learn about prior authorization and its importance in ophthalmology practices.
Why Prior Authorization Takes Longer in Ophthalmology Practices?
According to Medscape’s report mentioned in Becker’s ASC Review, 37% of ophthalmologists spend 10-19 hours per week on paperwork and administrative tasks, whereas 15% spend 20 hours or more. These admin duties include seeking payers’ prior approvals for specialized and high-cost ophthalmology services.
But why does prior authorization take longer in ophthalmology practices?
Here are some of the most common prior authorization challenges in ophthalmology practices.
Massive Request Volume
Several pre-authorization requests are submitted every day, resulting in a high volume. Harvard Health estimates suggest 35 million prior authorization requests are submitted each year, only on behalf of Medicare Advantage beneficiaries.
Insurers must review every request individually through peer-to-peer reviews, after which requests are either accepted or rejected.
The result is a substantial annual workload, contributing to processing delays across payers. Most insurers are unable to handle this increased workload, which ultimately results in delays in ophthalmology prior authorizations.
Complex Payer Requirements
First off, the prior authorization requirements are not consistent across payers. For instance, Blue Cross Blue Shield may require pre-authorization for newer medications, such as specialty ophthalmic drugs and intravitreal anti-VEGF therapies, depending on the indication and payer policy.
However, other insurers, such as Cigna, may waive this step depending on their policy. Additionally, requirements, formats, and criteria for submission may vary across payers.
But the toughest part? Ophthalmology service pre-authorization requirements are updated consistently. Thus, a procedure that did not previously require prior authorization may now require it because of payer policy changes.
The result? A more complicated process and delays, which become one of the biggest prior authorization challenges in ophthalmology.
Paper-Based Processes
Another major prior authorization challenge in ophthalmology practices is the paper-based processing. What’s more surprising is that research by JP Morgan claims that around 71% of providers still rely on manual processes for patient billing.
How does this matter? Manual processing is prone to errors, messy, and time-consuming. In such processes, providers rely on fax-based or non-integrated electronic systems, which remain slow and error-prone.
Conversely, digital submissions allow same-day viewing because they can be posted immediately.
Documentation Errors
As mentioned earlier, manual processing for pre-authorization requests increases the likelihood of encountering errors. The errors can occur anywhere from entering the patient’s information during registration to the front-desk verification.
A single error could mean instant rejection, delayed prior authorization, and a negatively impacted revenue cycle.
Some common documentation errors may include:
- Typos
- Spelling mistakes
- Swapping or rearranging numbers
Information errors mean the payer has incorrect or outdated details, resulting in the prior authorization request being rejected. The impact? The ophthalmology service rendered to the patient is unapproved until all request errors are rectified and resubmitted to the payer.
What’s New in Ophthalmology Prior Approval Guidelines
Preferred Practice Pattern® guidelines (“PPP”) help identify the components and characteristics of high-quality eye care. However, ophthalmology procedures often involve complex clinical and payer-specific authorization requirements that can be challenging for both providers and billing teams.
Therefore, several organizations, like AHIP and BCBSA, collaborated with the U.S. Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) to simplify prior authorization processes.
With this multi-year commitment, we will witness payers move from traditional and outdated systems to more streamlined methods, accelerating the prior authorization process in ophthalmology.
Prior Authorization Changes in 2026
The recent CMS interoperability and prior authorization reform initiatives and industry-wide payer modernization efforts, effective January 1, 2026, include:
- Fewer services now require in-network prior authorization.
- A 90-day transition period applies to patients switching insurance plans during treatment.
- Health plans must clearly communicate prior authorization decisions, such as guiding appeals and the steps.
- Denials based on clinical reasons must be reviewed or re-checked by a qualified medical professional (peer reviewers).
What We’re Anticipating for 2027
Anticipated updates for 2027 include several positive changes and improvements to counter current prior authorization challenges in ophthalmology. We expect:
- Wider implementation of FHIR® APIs for faster, real-time decision-making.
- Payers are targeting up to 80% of electronic prior authorization requests for real-time processing.
- Electronic submissions for improved transparency, reduced errors, and improved appeal duration.
- Standardized data formats and submission to reduce errors, streamline workflows, and boost turnaround times.
In 2027, we expect an increase in the rate of point-of-care authorization approvals for a faster, more efficient, and more reliable healthcare provider experience.
Ophthalmology Procedures with Complex Authorization Processes
Authorization challenges in ophthalmology can become more complex if billing professionals are unaware of the eye care procedures and services that require pre-authorization. From an AAPC-aligned perspective, sourced from the discussion thread:
Prior authorization is payer-specific and not procedure-specific. Therefore, requirements can vary based on:
- Patient’s insurance plan (Medicare, Medicare Advantage, Commercial, Medicaid)
- Medical necessity
- Elective vs. emergent service
The following procedures are commonly subject to prior authorization requirements in ophthalmology practices, although this varies significantly by payer, plan type, and clinical indication.
| Procedure | Description | CPT/HCPCS Code |
|---|---|---|
| Refractive Surgery | Surgical or laser-based procedure performed to reshape the cornea or replace the natural lens to correct refractive errors such as myopia, hyperopia, and astigmatism (e.g., LASIK). | 65767, 65771, 65772, 65775, 65785, 66985, 66999, S0800, S0810. |
| Ophthalmic Antibiotics | Topical or injectable antibiotic therapies, including moxifloxacin and erythromycin (used to treat bacterial eye infections like conjunctivitis). | J2280, J2281, J1364, J7099. |
| Intravitreal Anti-VEGF Injections | Administration of anti-VEGF agents directly into the vitreous cavity to inhibit abnormal blood vessel growth and reduce leakage in retinal conditions. | C9399, J0177, J0178, J0179, J2503, J2777, J2778, J3590, Q5124, Q5128. |
| Glaucoma Surgery | A range of surgical procedures aimed at lowering intraocular pressure by enhancing aqueous outflow or decreasing fluid production. | 0253T, 0449T, 0450T, 0474T, 0671T, 65820, 66150, 66155, 66160, 66170, 66172, 66174, 66175, 66179, 66180, 66183, 66184, 66185, 66989, 66991. |
| Eyelid and Brow Surgery | Procedures to remove extra skin, fat, or muscle from the eyelids or brow to fix drooping, sagging, or puffiness. | 15820, 15821, 15822, 15823, 67900, 67901, 67902, 67903, 67904, 67906, 67908, 67914-67917, 67921-67924. |
| Corticosteroid Implants and Injections | Steroid medications, given directly into or around the eye to reduce inflammation while limiting effects on the rest of the body. | J7311, J7312, J7313, J7314. |
| Cataract Surgery | Removal of the eye’s cloudy lens (usually replaced with an artificial lens to improve vision). | 66840, 66850, 66852, 66920, 66930, 66940, 66982, 66983, 66984, 66987, 66988, 66989, 66991. |
Key Factors Behind Prior Authorization Denials in Ophthalmology
Educating patients about payment guidelines and a procedure’s medical necessity may seem like a solution for authorization denials. However, these tactics are time-consuming and can slow down revenue for practices. So, what are healthcare providers supposed to do?
The most effective method to fight prior authorization denials is to prevent them from occurring in the first place. Sounds simple enough? Unfortunately, several factors can trigger pre-authorization denials, and billing professionals must be mindful of all of them.
Therefore, here is a comprehensive breakdown discussing the most common reasons for your understanding:
Clinical Criteria Complexity
Due to strict criteria, ophthalmology prior authorizations often result in denials if they lack precise details. For instance, if a patient requires cataract surgery, the service must be medically justified by, but not limited to:
- Visual acuity testing showcasing reduced vision
- Slit-lamp exam findings for cataract severity
- Refraction results that prove vision cannot be improved with corrective glasses
- Physician assessment and plan
- Patient-reported symptoms: difficulty in reading, driving, and other daily activities.
Essential Note: Even if minor information or formatting is wrong, a denial will be triggered.
Missing or Invalid Modifier Information
A modifier indicates changes to a procedure under certain circumstances that still do not qualify it for a separate CPT code from the one reported. These modifiers help billers specify clinical circumstances under which a procedure was performed.
Incomplete or inconsistent coding details, including missing modifiers when required in supporting documentation, can contribute to authorization delays or denials, both of which negatively impact revenue in their own ways.
Upon denial, the billing team would then rectify the error, provide complete procedure details, and resubmit the form, wasting valuable time and resources.
Confusion Between Pharmacy & Medical Problems
Prior authorization denials in ophthalmology practices often occur when a service falls between selective and medically necessary. This means the appended service does not have a distinct category and falls within a gray area.
Similarly, if an insurer cannot differentiate between a pharmaceutical and a purely medical service, the request may be delayed if not denied. When decisions are delayed, they often face denial.
Note: Certain specialty drugs may fall under either benefit, depending on the plan design, needing detailed benefit investigation.
Patient Ineligible on the Date of Service
The front desk typically checks for active insurance coverage during patient eligibility. However, if the staff overlooks it and sends a pre-authorization request for an uncovered patient, the result will be a rejection letter. For example, a patient may have an employer-sponsored medical coverage but has recently left their job, ceasing their health insurance coverage.
Similarly, if the patient is recently married, it changes their marital status and the coverage policy requirements.
Therefore, billing staff must always be proactive and allow services only after the patient is fully eligible. As a rule of thumb, always verify the patient’s:
- Name
- DOB
- Gender
- Payer ID
- Policy number
Peer-Review Errors
Did you know prior authorization reviews may not always be conducted by ophthalmology specialists, as payer-appointed physicians from general backgrounds are often involved.
Insurers typically have general healthcare practitioners reviewing the request, so they do not have the training or specialized information required. Therefore, they may not fully comprehend the necessity or urgency of the service.
Similarly, newer treatment options such as an FDA-approved drug may also not be reimbursed. The result? Unnecessary denials.
Experimental Services & Medication
Not all services are covered equally, and healthcare providers generally agree not to interfere with a payer’s coverage policy. However, certain insurers may consider new medications non-covered for reimbursement even if they are medically necessary.
For example, different carriers may have varying opinions on corneal topography, and billing teams must follow payer-specific guidelines.
Therefore, billing teams should be trained to review relevant payer guidelines to avoid pre-authorization denials.
Quick Insight: Prior authorization requirements may also vary based on place of service (e.g., office vs. ASC vs. hospital outpatient department) and site-of-care policies.
Resolve Authorization Challenges in Ophthalmology with NeuraBill
Insurance payers employ prior authorization as a measure for cost-controlling and revenue streamlining, but it often poses administrative and clinical challenges for healthcare providers. According to the American Academy of Ophthalmology (AAO), physicians spend two or more days negotiating with insurance payers, slowing down the revenue cycle.
Because of denials, patients have no alternative but to abandon recommended treatment or medication options, and that is something no ophthalmologist can stand to see.
Thus, if you continue to struggle with prior authorization challenges in your ophthalmology practice, consider opting for professional ophthalmology billing services to streamline workflows, reduce request denials, and accelerate reimbursement cycles.
